Purification of progenitor toxin of Clostridium botulinum type B strain Okra was undertaken by sequential steps of acid precipitation, extraction, ammonium sulfate precipitation, ribonuclease digestion, acid precipitation, protamine treatment, sulphopropyl-Sephadex chromatography, and Sephadex G-200 gel filtration. Two different molecular-sized toxins, named large (L) and medium (M) toxins, were obtained. L toxin was centrifugally homogeneous but electrophoretically heterogeneous. It contained 2.5 x 108 to 3.0 x 108 mean lethal doses per mg of nitrogen, and its sedimentation constant was 16S. M toxin was centrif'ugally and electrophoretically homogeneous. It contained 5.5 x 108 to 6.0 x 108 mean lethal doses per mg of nitrogen, and its sedimentation constant was 12S. The presence of both L and M toxins in spent culture was demonstrated. It seems justified, therefore, to call both progenitor toxins. Both consisted of toxic and nontoxic components. The toxic components of L and M toxins appeared to be identical with each other. The nontoxic component of L toxin was 12S and possessed a hemagglutinin activity of about 0.5% that of type A crystalline toxin; that of M toxin was 7S and possessed no hemagglutinin activity. They were antigenically related but not identical.
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Clostridium botulinum type A toxin was crystallized and its molecular weight was estimated to be 900,000 (12, 15) . It consists of two components, a neurotoxin and a hemagglutinin (11) . The neurotoxic component was obtained as a single entity with a molecular weight of 150,000, whereas the hemagglutinin component was obtained in three different forms with molecular weights of 290,000, 500,000, or 900,000 (4) .
Type E progenitor toxin, molecular weight of 350,000, consists of neurotoxic and nontoxic components of the same molecular weight, 150,000. The nontoxic component contains no hemagglutinin activity (8) . Although the dissociated toxic component plays the crucial role In parenteral toxicity, only progenitor toxin, defined as the complex of the toxic and nontoxic components, is significant as an oral toxin (9) .
The molecular weights reported for type B toxin vary from 9,000 to 500,000 (6, 7, 10, 19, 20) . Homogeneous type B toxin with a molecular weight of 165,000 or 167,000 was obtained by diethylaminoethyl (DEAE)-cellulose chromatography at pH 8.0 (1, 5) . This toxin must have been the dissociated toxic component analogous to those of types A and E.
No previous publication has identified which purified toxin is type B progenitor toxin, nor clarified its molecular structure. We attempted, theref'ore, to purify type B progenitor toxin without inducing possible molecular aggregation or disaggregation during the processes of purification. Different molecular-sized progenitor toxins were obtained. We attempted to characterize the molecular structure of each progenitor toxin in comparison with those of other types.
MATERIALS AND METHODS
Bacterial strain. C. botulinum type B strain Okra was used. A suspension of about 107 viable spores per ml was kept frozen and used as the inoculum for toxin production.
Culture for toxin production. The medium for toxin production was composed of 2% peptone (for toxin production; Mikuni Kagaku Sangyo Co., Tokyo), 0.5% yeast extract (Oriental Yeast Kogyo Co., Osaka), 0.5% glucose, and 0.025% sodium thioglycolate. It was adjusted before autoclaving to pH 7.0 with a 10% NaOH solution. For toxin production, 1 ml of the spore suspension was inoculated into 5 liters of medium, which was incubated at 30 C for 4 days.
Chemicals and reagents. SP-Sephadex, C-50 (medium), DEAE-Sephadex, A-50 (medium), and Sephadex G-200 (particle size, 40 to 120 gm) were Determination of toxin potency. Toxin potency was determined mostly by the time-to-death method by intravenous injection into mice (2, 17) . I'ryptic activation was performed in the same way as for type E progenitor toxin (8) . From a standard dose response curve prepared with trypsinized type B progenitor toxin containing both L and M toxins, the intraperitoneal mean lethal dose (LD,0) per milliliter was estimated.
Since the quantity of toxin in each fraction of sucorse density gradient centrifugation was too small to be determined by the bioassay, the reversed passive hemagglutination test was performed with sheep erythrocytes sensitized with anti-M toxin immunoglobulin purified from crude type B antitoxin on a column of CNBr-activated Sepharose 4B (Pharmacia Fine Chemicals) conjugated with purified M toxin. The details of affinity chromatography, sensitization of sheep erythrocyes, and hemagglutination tests are described elsewhere (18) .
Determination of protein. Protein was determined by the method of Lowry et al. (14) , with bovine serum albumin as the standard.
Polyacrylamide gel electrophoresis. Polyacrylamide gel of 4.5% and the tray buffer were prepared according to Reisfeld et al. (16) . Electrophoresis was carried out by applying a current of 2 to 3 mA per column for 3 h at room temperature. After electrophoresis, the gel columns were stained in a 1% amido black 10B solution in 7% acetic acid.
Agar gel double diffusion. Fig. 1 .
For step 1 (acid precipitation [6] ), a whole culture was adjusted to pH 4.0 with 3 N H2SO4 and kept standing overnight at room temperature to allow the precipitate to settle. The supernatant fluid was removed by siphoning; to the remaining precipitate about 4 volumes of distilled water was added to dissolve acid-soluble materials, and the mixture was allowed to stand overnight. The supernatant fluid was removed by siphoning; the precipitate was packed by centrifugation at 3,800 x g for 10 min at 4 C.
For step 2 (extraction), the washed acid precipitate obtained from a 10-liter culture was extracted two or three times with 150 ml of 0.2 M phosphate buffer, pH 6.0, by centrifugation at 8,600 x g for 20 min at 4 C.
For step 3 (ammonium sulfate precipitation), 0.25 volumes of a saturated ammonium sulfate solution kept at room temperature was added to the cold extract. The mixture was allowed to stand for 1 h at room temperature and centrifuged at 3,800 x g for 10 min at 4 C. To the supernatant fluid, taken by decantation, solid ammonium sulfate was added to 60% saturation. The mixture was allowed to stand overnight at 4 C. The toxin precipitate was collected by centrifugation at 3,800 x g for 10 min at 4 C.
For step 4 (ribonuclease digestion), the precipitated toxin was dissolved in 50 ml of 0.2 M phosphate buffer, pH 6.0; it was dialyzed against 2 liters of the same buffer for 24 h at 4 C. The toxic solution in the dialysis casing was digested with ribonuclease (50 Ag/ml) for 5 h at 30 C.
For step 5 (second acid precipitation and extraction), the precipitate formed during the ribonuclease digestion was removed by centrifugation. The supernatant fluid containing the toxin was adjusted to pH 4.2 with 1 M acetic acid and dialyzed against 0.05 M acetate buffer, pH 4.2, for 48 h at 4 C. A white precipitate appeared during dialysis. It contained the toxin and was collected by centrifugation at 8,600 x g for 10 min at 4 C. The toxic precipitate was washed twice, first with 50 ml of 0.05 M acetate buffer, pH 4.2, and then with 50 ml of the same buffer containing 0.1 M NaCl. The washed precipitate was extracted with 0.05 M acetate buffer (pH 4.2) containing 0.5 M NaCl for 10 min at 37 C followed by centrifugation at 8,600 x g for 10 min at 10 C. The extraction was repeated two more times, and the three extracts were combined.
For step 6 (protamine treatment), a 2% protamine sulfate solution was added dropwise to the extract, which was kept stirred on a mechanical stirrer to a final protamine concentration of 0.06% (wt/vol). The mixture was allowed to stand for 20 (Fig. 3) .
Separation of toxic from nontoxic component. L and M toxin pooled fractions were chromatographed on DEAE-Sephadex A-50 (0.9 by 10 cm) equilibrated with 0.01 M phosphate buffer, pH 8.0, with a linear gradient of NaCl from 0 to 0.5 M in 200 ml of the same buffer (9) .
RESULTS
Purification of type B progenitor toxin and examinations for purity. The recovery and specific toxicity at each step of purification are shown in Table 1 Table 1 ). Through all the steps of purification, the activation ratio (the ratio of the toxicity after trypsinization to that before) did not change appreciably. Toxicity of L and M toxins increased by 4-to 30-fold by tryptic activation.
M toxin at 192 gg/ml showed no hemagglutinin activity, whereas L toxin at 123 jg/ml or higher concentrations showed positive agglutination of chicken erythrocytes. Under the same conditions, crystalline type A toxin at 0.6 jg/ml or higher concentrations gave positive hemagglutination.
In polyacrylamide gel electrophoresis at pH 4.0, purified L and M toxins formed a major and one or more minor bands, one of which possessed a relative mobility corresponding to that of the other toxin. After another run of gel filtration of each, M toxin showed a single band, but L toxin still showed two to four bands (Fig.  4) .
In ultracentrifugal analysis at pH 4. (Fig.  6 ).
In Sephadex G-200 gel filtration at pH 8.0, dissociated M toxin was eluted in a single peak at a position close to that for alcohol dehydrogenase, its molecular weight being 150,000. The elution position of the toxic peak was identical to that of the single peak of M toxin (Fig. 7) .
In ultracentrifugal analysis at pH 6.0 of each M toxin component separated chromatographically, a sedimentation constant of 7S was obtained for each.
In agar gel double-diffusion tests at pH 6.0, M toxin formed two precipitin lines. The single lines formed with the toxic components of each toxin coalesced, whereas the lines of the nontoxic components of M and L toxins only partially coalesced (Fig. 8) .
DISCUSSION
We intended to purify and characterize the progenitor toxin of C. botulinum type B, which had not been obtained in an ultimately pure state. To prevent molecular dissociation, any process that had to be performed at pH 7 or above was avoided. For the first step of purification, acid precipitation (6, 10) seemed to be simplest and most economical for handling a large batch of culture. Extraction of the toxin from the acid precipitate was accomplished most efficiently with 0.2 M phosphate buffer, pH 6 .0, which had been used to extract progenitor toxin from type E organisms (8) . The extract became insoluble, however, when equilibrated with a buffer below pH 5, probably due to the presence of a large amount of ribonucleic acid in the acid precipitate. To make the toxic extract soluble below pH 5, which is suitable for SPSephadex chromatography, treatments with ribonuclease and protamine were applied. The ribonuclease treatment removed a large amount of RNA but prevented precipitation only partially. The protamine treatment, on the other (6, 10) , but the latter is at least 2 to 2.5 times higher than the highest value ever reported for type B toxin (6) . It There is no reason to believe that either one or both of L and M toxins were artifacts, because both were demonstrated in supernatants of spent cultures by Sephadex G-200 gel filtration and sucrose density gradient centrifugation performed at a pH value and ionic strength simulating the spent culture. The physiological significance of L and M toxins for the organisms is not known. The sedimentation constants of L and M toxins were found to be 16S and 12S, respectively. The figure for L toxin agrees with the one reported by Duff et al. (6) , Wagman and Bateman (20) , and Schantz and Spero (19) . The molecular weight of L toxin, therefore, was estimated to be about 500,000. From the same elution volume in gel filtration and the same sedimentation constant as for type E progenitor toxin (8) , the molecular weight of M toxin was estimated to be about 350,000.
Schantz and Spero (19) estimated the sedimentation constant of type B toxin in culture as 16S. Duff et al. (6) reported that their purified type B toxin contained a minor component of 10.9S in addition to the major one of 14.9S, and that the main toxin purified by extracting the acid precipitate with 0.2 M succinate buffer, pH 5.5, instead of 0.05 M calcium chloride solution at pH 6.0 was 12.7S. The distribution of different molecular-sized toxins in culture, however, was not examined by these authors. In the present investigation, the presence of both L and M toxins in the starting material was demonstrated; therefore, it does not seem justified to assume that L or M toxin, or both, is an artifact resulting from aggregation or disaggregation of some other toxin molecules. Another strain of C. botulinum type B, strain QC, which is a nonproteolytic strain, was also found to produce two different molecular-sized toxins with the same sedimentation constants as those of L and M toxins of strain Okra (unpublished data).
In gel filtration at pH 4 10, 1974 component of L toxin, therefore, was estimated to also be about 150,000, and that of the nontoxic component was estimated to be 350,000, assuming that the molecular weight of L toxin is 500,000 (6, 20) .
Agar gel double-diffusion tests indicate that the nontoxic component of L toxin may be composed of two subcomponents, one antigenically related to the nontoxic component of M toxin and the other not contained by M toxin and associated with the hemagglutinin activity. Under conditions that allow M toxin to dissociate into the two components, L toxin also dissociates into the two, but the nontoxic component of L toxin does not dissociate further. This suggests that the bond connecting the two subcomponents is a stronger one.
At the present moment, both L and M toxins seem to be entitled to be called progenitor toxins constituting oral toxins to man and animals according to the definition described by Lamanna and Sakaguchi (13) .
